The pharmaceutical community is excited by retatrutide, a new dual GIP and GLP-1 target that’s showing impressive results in preliminary read more research. This treatment works by replicating natural hormones to affect appetite and boost feelings of satiety, ultimately resulting in considerable fat reduction . While still under review and not re